Arteric Technology Utilized in Hypertension Medication Adherence Study at

Baylor College of Medicine

OnTimeRx Automated Reminder Service Tested in Stroke Prevention Program Targeting

African-American Women.

Summit, NJ, May 08, 2017 --(PR.com)-- Arteric (http://arteric.com), a healthcare marketing agency built
on a foundation of state-of-the-art software engineering, today announced that Baylor College of
Medicine is implementing OnTimeRx Automated Reminder Service in a pilot study[1] investigating the
efficacy of smartphone-based services to improve medication adherence. The study is funded by The
Lone Star Stroke Consortium, which is a Texas-based collaboration of major stroke centers, and the
Texas Nursing Association-District 9.

OnTimeRx Automated Reminder Service provides Web-based reminder-scheduling and notification

messages that are delivered by text message, phone call or email. Developed by Arteric President Hans
Kaspersetz and pharmacist Susan Torrico, a pioneer in the field, OnTimeRx Automated Reminder
Service is the most recent addition to the OnTimeRx adherence software collection.

Other OnTimeRx adherence products include apps for the iPhone and iPad, for

Android smartphones, and for Windows desktop computers. These software apps provide reminders
in the form of alarm sounds and/or on-screen notices as an alternative to text messages, phone calls or
email.

According to study researcher Vanessa Monroe, Clinical Assistant Professor at Prairie View A&M
University College of Nursing and PhD Candidate at Texas Woman's University-Houston, African
American women have significantly higher levels of hypertension as opposed to non-African
Americans.[2],[3] Medication nonadherence can cause these women to develop a decreased threshold for
stroke development or an increased progression of cardiovascular disease. We're very interested in
determining if the automated phone and email reminders sent by OnTimeRx improve medication
adherence in this at-risk population. Monroe continued, Preliminary results from a very small patient
population look promising. We're in the midst of adding more patients to the study.

According to Ms. Torrico, a career pharmacist, I've always been a proponent of medication adherence. I
conceived OnTimeRx in 2000 after discovering that many transplant patients lose their newly
transplanted organs simply because they don't adhere to their antirejection medications. Sadly, adherence
remains a complex and vexing challenge, and this is why we continue to promote and update
OnTimeRx with additional functionality as communication technology evolves.

Mr. Kaspersetz, founder and President of Arteric adds, The beauty of developing software in the
healthcare space is the potential for helping people live longer, healthier lives. It's inspiring to see
OnTimeRx being evaluated for its capacity do just that.

Page 1/3
PR.com Press Release Distribution Terms of Use
For information about OnTimeRx products, contact Jon Fisher at 201.558.9910.
For information about the clinical trial, contact Vanessa Monroe at 832.971.8682.

Learn more at Arteric.com

About Arteric
Arteric is a digital marketing agency built on a foundation of technology expertise -software engineering,
search engine optimization and search engine marketing. Arteric develops the strategy and the software -
Web sites, mobile apps, and Web applications - that drive pharmaceutical and biotechnology digital
marketing campaigns and connect the public and healthcare professionals with information about
life-changing therapies, technologies and devices.

Contact
Ross O'Shea
Arteric Public Relations
201.558.9910
Ross@arteric.com

iPhone and iPad are trademarks of Apple Inc., registered in the U.S. and other countries.
Android is a trademark of Google Inc.
Windows is a trademark of Microsoft Corporation.

References
[1] Monroe V, Dello Stritto R, Langford R, Young A. (2017). Texas Woman's
University-Houston.Testing a Smartphone Application Intervention to Improve Medication Adherence in
African American Female Clinic Patients with Unstable High Blood Pressure: A Two Group Randomized
Control Trial. Presented at the Southern Nurse Research Society Symposium. Dallas, Texas.

[2] Taylor J, Peternell, B, Smith, Jennifer J. (2013). Attitudes toward genetic testing for hypertension
among African American women and girls. Nursing Research and Practice. doi:10.1155/2013/341374

[3] Still C, Craven T, Freedman B, et al. (2015). Baseline characteristics of African Americans in the
systolic blood pressure intervention trial. Journal of the American Society of Hypertension, 9(9),
670-679. doi:10.1016/j.jash.2015.06.012

Page 2/3
PR.com Press Release Distribution Terms of Use
Contact Information:
Arteric
Ross O'Shea
201.546.9910
Contact via Email
http://arteric.com

Online Version of Press Release:

You can read the online version of this press release at: http://www.pr.com/press-release/715608

News Image:

Page 3/3
PR.com Press Release Distribution Terms of Use